Skip to main content
Psychedex

Psilocybin mushrooms

4-phosphoryloxy-N,N-dimethyltryptamine

1Provenance card

the boundary, as counts

Sources

3934 with DOI

13 strong · 25 moderate · 1 weak

Compilations

32026-05-14T02:50:22.022Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09 · 1 other run

Decisions

59last ruled 2026-10-15

33 awaiting a ruling

Issued documents

62026-10-15T07:39:49.515Z

notice · info card · emergency

Searches

310 with no results

queries and counts on the build

Claims checked

8368 supported

68 supported · 15 not

Correspondence

0received

consent field ships in Phase 4

Edges

313

derivations recorded for this entity

Complete over 39 sources, 3 compilations, and 59 decisions.Not here: the private journal (never); 33 proposals awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/psilocybin-mushrooms/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-15issueIssued emergency
  2. 2026-10-15issueIssued info_card
  3. 2026-10-15issueIssued notice
  4. 2026-10-15srcSingle-Dose Psilocybin Treatment for Major Depressive Disorder
  5. 2026-10-15srcEffects of Psilocybin-Assisted Therapy on Major Depressive Disorder
  6. 2026-10-15srcSerotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
  7. 2026-10-15srcClassic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
  8. 2026-10-15srcFlashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
  9. 2026-10-15srcMatrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms
  10. 2026-10-15srcBiochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review
  11. 2026-10-15srcClinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis
  12. 2026-10-15srcSafety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances
  13. 2026-10-15srcChallenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse
  14. 2026-10-15srcRecent advances in the neuropsychopharmacology of serotonergic hallucinogens
  15. 2026-10-15srcPsychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies
  16. 2026-10-15srcGlobal species diversity and distribution of the psychedelic fungal genus Panaeolus
  17. 2026-10-15srcPrevalence and associations of challenging, difficult or distressing experiences using classic psychedelics
  18. 2026-10-15srcEfficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review
  19. 2026-10-15srcMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
  20. 2026-10-15srcPsychiatry & the psychedelic drugs. Past, present & future
  21. 2026-10-15srcClassic psychedelics and the treatment for alcoholism
  22. 2026-10-15srcPsychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic
  23. 2026-10-15srcPsychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
  24. 2026-10-15srcPsilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
  25. 2026-10-15srcPsilocybin desynchronizes the human brain
  26. 2026-10-15srcPositive expectations predict improved mental-health outcomes linked to psychedelic microdosing
  27. 2026-10-15srcSingle-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
  28. 2026-10-15srcDynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China
  29. 2026-10-15srcPsychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System, 2023-2024
  30. 2026-10-15srcREBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
  31. 2026-10-15srcAdverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
  32. 2026-10-15srcPrediction of psilocybin response in healthy volunteers
  33. 2026-10-15srcBioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice
  34. 2026-10-15srcThe entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
  35. 2026-10-15srcExploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps
  36. 2026-10-15srcPharmacokinetics of Psilocybin: A Systematic Review
  37. 2026-10-15srcHofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology? A Systematic Review
  38. 2026-10-15srcHallucinogen Persisting Perception Disorder After Psilocybin Consumption: A Case Study
  39. 2026-10-15srcPsilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
  40. 2026-10-15srcPsilocin identified in a DUID investigation
  41. 2026-10-15srcThe content of Psilocybin in Norwegian Psilocybe semilanceata
  42. 2026-10-15srcThe Heffter Research Institute: past and hopeful future
  43. 2026-10-15publicationPublication — publishagent-psx
  44. 2026-10-05revisionr4.a2
  45. 2026-09-27runbrief run
  46. 2026-09-27revisionr4.a1
  47. 2026-09-04issueIssued emergency
  48. 2026-09-04issueIssued info_card
  49. 2026-09-04issueIssued notice
  50. 2026-05-15publicationPublication — backfill
  51. 2026-05-14proposaltolerance
  52. 2026-05-14proposalwithdrawal
  53. 2026-05-14proposaldependence · full
  54. 2026-05-14proposaltoxicity
  55. 2026-05-14proposaldose_tier · heavy
  56. 2026-05-14proposaldose_tier · strong
  57. 2026-05-14proposaldose_tier · common
  58. 2026-05-14proposaldose_tier · light
  59. 2026-05-14proposaldose_tier · threshold
  60. 2026-05-14proposalcontraindication · other
  61. 2026-05-14proposalcontraindication · age
  62. 2026-05-14proposalcontraindication · pregnancy_breastfeeding
  63. 2026-05-14proposalcontraindication · cardiovascular
  64. 2026-05-14proposalcontraindication · other
  65. 2026-05-14proposalcontraindication · other
  66. 2026-05-14proposalcontraindication · psychiatric
  67. 2026-05-14proposalcontraindication · psychiatric
  68. 2026-05-14revisionRevision 4
  69. 2026-05-14genGeneration — pipeline-v5 · with 8 morepipeline-v5
  70. 2026-05-14rungeneration run
  71. 2026-05-13proposaltimeline · oral · afterglow
  72. 2026-05-13proposaltimeline · oral · resolution
  73. 2026-05-13proposaltimeline · oral · peak
  74. 2026-05-13proposaltimeline · oral · come_up
  75. 2026-05-13proposaltimeline · oral · onset
  76. 2026-05-13proposaltimeline · oral · afterglow
  77. 2026-05-13proposaltimeline · oral · resolution
  78. 2026-05-13proposaltimeline · oral · peak
  79. 2026-05-13proposaltimeline · oral · come_up
  80. 2026-05-13proposaltimeline · oral · onset
  81. 2026-05-13proposalduration · oral · aftereffects
  82. 2026-05-13proposalduration · oral · total
  83. 2026-05-13proposalduration · oral · offset
  84. 2026-05-13proposalduration · oral · peak
  85. 2026-05-13proposalduration · oral · come_up
  86. 2026-05-13proposalduration · oral · onset
  87. 2026-05-13proposaldosage · oral
  88. 2026-05-13proposaltolerance
  89. 2026-05-13proposalwithdrawal
  90. 2026-05-13proposaldependence · full
  91. 2026-05-13proposaltoxicity
  92. 2026-05-13proposaldose_tier · heavy
  93. 2026-05-13proposaldose_tier · strong
  94. 2026-05-13proposaldose_tier · common
  95. 2026-05-13proposaldose_tier · light
  96. 2026-05-13proposaldose_tier · threshold
  97. 2026-05-13proposalcontraindication · age
  98. 2026-05-13proposalcontraindication · pregnancy_breastfeeding
  99. 2026-05-13proposalcontraindication · cardiovascular
  100. 2026-05-13proposalcontraindication · other
  101. 2026-05-13proposalcontraindication · other
  102. 2026-05-13proposalcontraindication · psychiatric
  103. 2026-05-13proposalcontraindication · psychiatric
  104. 2026-05-13revisionRevision 3
  105. 2026-05-13genGeneration — pipeline-v5 · with 7 morepipeline-v5
  106. 2026-05-13rungeneration run
  107. 2026-04-25rungeneration run
  108. 2026-03-17importImported from Curiosity v1
  109. 2026-03-17publicationPublication — backfill
  110. 2026-03-17revisionRevision 1

The same entries, as forms: six forms.